Track Hikma Pharmaceuticals PLC's goodwill ($390M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Hikma Pharmaceuticals PLC (HKMPY) currently reports a goodwill of $390M as of June 2026. That compares with $390M in the prior-year period — down 1.0% year over year. Use the charts on this page to explore Hikma Pharmaceuticals PLC's goodwill history and peer comparisons.
Hikma Pharmaceuticals PLC's goodwill decreased from $390M to $390M — a 1.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Hikma Pharmaceuticals PLC reported $390M in goodwill as of June 2026. That compares with $390M in the prior-year period — down 1.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current goodwill of $390M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hikma Pharmaceuticals PLC, and consider following HKMPY for alerts when major investors trade the stock.